Home
Scholarly Works
Apixaban in patients with metastatic cancer: a...
Conference

Apixaban in patients with metastatic cancer: a randomized phase II feasibility study

Authors

Liebman H; Levine MN; Deitchman D; Julian J; Escalante CP; O'Brien MC; Ramirez LM; Weise-Kelly L; Solymoss S

Volume

7

Pagination

pp. 792-793

Publisher

ELSEVIER SCIENCE INC

Publication Date

July 1, 2009

Conference proceedings

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

ISSN

1538-7933

Contact the Experts team